Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
148.41
+0.60 (0.41%)
At close: Dec 4, 2025, 4:00 PM EST
148.94
+0.90 (0.61%)
Pre-market: Dec 5, 2025, 5:44 AM EST
Axsome Therapeutics Employees
Axsome Therapeutics had 683 employees as of December 31, 2024. The number of employees increased by 138 or 25.32% compared to the previous year.
Employees
683
Change (1Y)
138
Growth (1Y)
25.32%
Revenue / Employee
$821,761
Profits / Employee
-$336,057
Market Cap
7.48B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 683 | 138 | 25.32% |
| Dec 31, 2023 | 545 | 162 | 42.30% |
| Dec 31, 2022 | 383 | 275 | 254.63% |
| Dec 31, 2021 | 108 | 48 | 80.00% |
| Dec 31, 2020 | 60 | 15 | 33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AXSM News
- 13 hours ago - Axsome Therapeutics, Inc. (AXSM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - 2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool
- 15 days ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - 2 Monster Stocks in the Making - The Motley Fool
- 4 weeks ago - Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy - GlobeNewsWire
- 4 weeks ago - Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics - GlobeNewsWire
- 4 weeks ago - Axsome: Alzheimer's Disease Agitation sNDA Adds Optionality, Not A Thesis Changer - Seeking Alpha
- 4 weeks ago - Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript - Seeking Alpha